| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.0M | +23.3% |
| Cost of Revenue | $15.6M | +47.4% |
| Gross Profit | $23.4M | +11.2% |
| R&D Expense | $3.3M | -2.0% |
| SG&A Expense | $22.8M | +20.2% |
| Operating Income | -$2.6M | -117.9% |
| Interest Expense | $2.0M | +89.2% |
| Pre-tax Income | -$3.8M | -452.7% |
| Income Tax | $15K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.9M | -30.2% |
| Accounts Receivable | $5.4M | +57.2% |
| Inventory | $15.2M | +1572.0% |
| Current Assets | $41.0M | +52.8% |
| Total Assets | $76.1M | +139.8% |
| Current Liabilities | $19.9M | +22.8% |
| Long-term Debt | $29.8M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $969K | -85.8% |
| Capital Expenditures | $26K | — |
| Investing Cash Flow | -$40.0M | -5063.1% |
| Financing Cash Flow | $32.6M | +3505.7% |
| Free Cash Flow | $943K | -86.2% |
| -93.9% |
| Net Income | -$3.8M | -308.4% |
| EPS (Basic) | -$0.15 | -275.0% |
| Total Liabilities |
| $51.7M |
| +217.9% |
| Stockholders' Equity | $24.4M | +57.8% |